GlassScriptPhysician profile
Beatric Muma
NPI 1972079879
$10,211.26
in general payments reported to CMS, 2019-2025
48 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,850 · 2022: $1,874 · 2023: $2,209 · 2024: $2,130 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,378 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,378.28 |
| Education | $109.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,233.22 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $973.59 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $804.87 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $798.69 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $485.73 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Antares Pharma, INC. | $439.55 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $403.97 | 2022-2025 | |
| Urovant Sciences INC | $387.62 | 2021-2022 | |
| Cipla USA INC. | $370.58 | 2021 | |
| Endo Pharmaceuticals INC. | $370.37 | 2021-2024 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $346.64 | 2022-2025 | Pylarify |
| Pfizer INC. | $312.58 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $284.61 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $232.48 | 2021-2025 | |
| Teleflex LLC | $216.49 | 2021-2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $214.37 | 2023-2025 | Jatenzo, Eligard |
| Alnylam Pharmaceuticals INC. | $195.42 | 2021-2025 | Givlaari |
| Myovant Sciences INC. | $187.18 | 2021-2022 | |
| Accord Healthcare, INC. | $176.64 | 2024 | |
| Dendreon Pharmaceuticals LLC | $174.36 | 2021-2025 | Provenge |
| Endo USA, INC. | $160.95 | 2024-2025 | Aveed, Xiaflex |
| Medtronic, INC. | $139.43 | 2022-2023 | Interstim |
| Tolmar Pharmaceuticals, INC. | $136.80 | 2021-2022 | |
| Immunitybio, INC. | $135.17 | 2025 | |
| Clarus Therapeutics INC. | $130.81 | 2021 | |
| Novartis Pharmaceuticals Corporation | $113.81 | 2022-2025 | |
| Boston Scientific Corporation | $85.72 | 2022-2025 | Spaceoar Vue System - 10ml |
| Novo Nordisk INC | $83.25 | 2024-2025 | Rivfloza |
| Axonics, INC. | $71.53 | 2023 | Axonics |
| Astrazeneca Pharmaceuticals LP | $63.61 | 2021-2024 | Lynparza |
| Acerus Pharmaceuticals Corporation | $60.99 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $40.10 | 2025 | |
| Urogen Pharma, INC. | $38.14 | 2025 | |
| Myriad Genetic Laboratories, INC. | $30.34 | 2021-2022 | |
| Caris Mpi, INC. | $29.03 | 2025 | Mi Cancer Seek |
| Sun Pharmaceutical Industries INC. | $28.10 | 2025 | |
| Tempus Ai, INC | $27.14 | 2024 | Xt Cdx |
| Amgen INC. | $26.27 | 2021-2022 | |
| 180 Medical, INC. | $25.43 | 2022 | |
| Telix Pharmaceuticals | $25.32 | 2025 | Illuccix |
| Halozyme INC | $24.77 | 2023 | |
| Janssen Scientific Affairs, LLC | $19.78 | 2021 | |
| Bioprotect Medical, INC. | $19.37 | 2025 | Bioprotect Balloon Implant System |
| E.R. Squibb & Sons, L.L.C. | $19.32 | 2025 | Opdivo |
| Verity Pharmaceuticals INC. | $18.55 | 2025 | Tlando |
| Abc Home Medical Supply, INC. | $17.04 | 2024 | |
| Foundation Medicine, INC. | $16.99 | 2023 | Foundationone Liquid Cdx |
| Azurity Pharmaceuticals, INC. | $14.54 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatric Muma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.